SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-044788
Filing Date
2021-08-17
Accepted
2021-08-17 08:35:07
Documents
14
Period of Report
2021-08-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-8k_20210817.htm   iXBRL 8-K 35145
2 EX-99.1 apvo-ex991_35.htm EX-99.1 22026
3 GRAPHIC ghp55odq0xoe000001.jpg GRAPHIC 10930
  Complete submission text file 0001564590-21-044788.txt   213183

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA apvo-20210817.xsd EX-101.SCH 5816
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20210817_lab.xml EX-101.LAB 20227
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20210817_pre.xml EX-101.PRE 12114
7 EXTRACTED XBRL INSTANCE DOCUMENT apvo-8k_20210817_htm.xml XML 3670
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 211181015
SIC: 2834 Pharmaceutical Preparations